Certa Therapeutics
PrivateLast Round
Early Funding
Jun 4, 2018
Total Funding Raised
$19.11M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Certa Therapeutics is a biotechnology company that develops precision therapies for the treatment of fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Certa Therapeutics Comparables
Compare Certa Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mediar Therapeutics | 83% | |
| Emerald Health Pharmaceuticals | 78% | |
| Pulmongene | 78% | |
Certa Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 4, 2018 |
Certa Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Melbourne | Early Funding |
| Uniseed | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors increased 58% MoM.
- Apr 16, 2026
Monthly visitors increased 107% MoM.
Certa Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Certa Therapeutics's valuation, stock price, and market status.